From Nature to Drug Discovery: The Indole Scaffold as a ‘Privileged Structure’

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|9|7|782-793

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.9, Iss.7, 2009-06, pp. : 782-793

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rhodanine as a Privileged Scaffold in Drug Discovery

By  

Current Medicinal Chemistry, Vol. 16, Iss. 13, 2009-05 ,pp. : 1596-1629

Bentham Science Publishers

Access to resources Recommend Favorite

Quinoline as a Privileged Scaffold in Cancer Drug Discovery

By  

Current Medicinal Chemistry, Vol. 18, Iss. 10, 2011-04 ,pp. : 1488-1508

Bentham Science Publishers

Access to resources Recommend Favorite

2-Arylbenzothiazole as a Privileged Scaffold in Drug Discovery

By  

Current Medicinal Chemistry, Vol. 16, Iss. 19, 2009-07 ,pp. : 2430-2440

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Modeling of Knottins, a Promising Molecular Scaffold for Drug Discovery

By  

Current Pharmaceutical Design, Vol. 17, Iss. 38, 2011-12 ,pp. : 4337-4350

Bentham Science Publishers

Access to resources Recommend Favorite

Nature's bounty – drug discovery from the sea

By Bowling John J   Kochanowska Anna J   Kasanah Noer   Hamann Mark T  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 11, 2007-11 ,pp. : 1505-1522

Informa Healthcare

Access to resources Recommend Favorite